ARTL News and Press, Artelo Biosciences Inc. From 06/01/22

SOLANA BEACH, Calif., June 01, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL) , a clinical-stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the ...

The following slide deck was published by Artelo Biosciences, Inc. in conjunction with this event. For further details see: Artelo Biosciences (ARTL) Investor presentations - Slideshow

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16 th - 20 th , 2022, where 36 SmallCap, MicroCap and NanoCap public companies will be presenting via virtual webcast to a global investor audience. The Spring in...

SOLANA BEACH, Calif., May 16, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. “Artelo” or the “Company”) (NASDAQ: ARTL) , a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endoc...

SOLANA BEACH, CA / ACCESSWIRE / May 13, 2022 / Artelo Biosciences, Inc. "Artelo" or the "Company") (NASDAQ:ARTL) , a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory D...

Artelo Biosciences press release (NASDAQ:ARTL): Q1 GAAP EPS of -$0.05 beats by $0.03. Company had approximately $23.5 million in cash and investments, compared to $25.6 million as of December 31, 2021. For further details see: Artelo Biosciences GAAP EPS of -$0.05 beats by $0.03

$23.5 Million in Cash and Investments as of March 31, 2022, Expected to Support Completion of the CAReS Trial and Operations Into Second Half of 2023 Results of Phase 1b CAReS Trial Anticipated in Q3 2022 SOLANA BEACH, Calif., May 12, 2022 (GLOBE NEWSWIRE) -- Artelo ...

Solana Beach, California--(Newsfile Corp. - April 25, 2022) - Artelo Biosciences, Inc. (NASDAQ: ARTL) , a clinical stage pharmaceutical company developing therapeutics that modulate lipid-signaling pathways, including the endocannabinoid system, today announced that Gregory Gorgas, Chief ...

Penny stocks are a great way to make quick money, but they aren’t for the faint of heart. Whether it’s something to do with global headlines or company-specific catalysts, there are countless ways to make money with penny stocks . Knowing how to trade them and use data...

Artelo Biosciences (NASDAQ:ARTL) said ART27.13 has shown promising pre-clinical results in protecting human muscle cells from cancer-induced muscle degeneration (cachexia) via a CB2 mediated mechanism of action. The company said ART27.13, a peripherally selective G-Protein Coupled Receptor (G...